TL;DR
Unweighted pipeline is the total dollar value of all open opportunities at face value — without any stage probability, win rate, or confidence adjustment applied. It is the gross pipeline number used for coverage ratio calculations and capacity planning. For most operators, weighted pipeline is the more decision-useful metric for forecasting; unweighted pipeline is more useful for capacity sizing and coverage ratio tracking.
What is unweighted pipeline?
Unweighted pipeline (also called gross pipeline, total open pipeline, or face-value pipeline) is the sum of all open opportunity values without any probability adjustment. A $100K deal at Stage 1 contributes $100K to unweighted pipeline, regardless of the historical likelihood that Stage-1 deals close.
It is the contrast metric to weighted pipeline, which multiplies each deal's value by its stage probability (a $100K Stage-1 deal at 25% historical close rate contributes $25K). Both views are useful for different purposes — and operators frequently confuse which one they're looking at.
Unweighted pipeline is the right metric for pipeline coverage ratio calculations because coverage is benchmarked against historical win rates that already incorporate the stage-probability mix. A 3:1 coverage ratio target means $3 of unweighted pipeline per $1 of quota, with the historical win rate doing the implicit weighting.
Why unweighted pipeline matters for operators
Unweighted pipeline is the cleanest measure of pipeline volume — how much there is, before any confidence assumptions. For capacity-sizing decisions (do we have enough deals for X reps to work through?), unweighted is the right view because it doesn't pre-discount opportunities that haven't yet been worked.
Unweighted pipeline also exposes coverage problems faster than weighted pipeline. Coverage ratios are typically calculated against unweighted pipeline at quarter start. A team with $14M of unweighted pipeline against a $5M quarterly quota has 2.8:1 coverage — below the 3:1 SaaS benchmark, immediately diagnostic.
The trap is using unweighted pipeline for forecasting. A team forecasting against unweighted pipeline assumes 100% conversion across all stages — wildly optimistic. The forecast number must apply a stage-probability adjustment (weighted pipeline) or a historical-conversion adjustment (cohort-conversion forecasting). Using unweighted pipeline directly for revenue prediction produces structural over-forecasting.
Unweighted pipeline formula
Unweighted Pipeline ($) = Σ (Open Opportunity Value)
Open opportunities = all deals not yet closed-won or closed-lost.
Example — mid-market SaaS quarter start:
Stage 1 (Prospect): 90 opps × $42K avg = $3.78M
Stage 2 (Discovery): 65 opps × $46K avg = $2.99M
Stage 3 (Demo): 48 opps × $48K avg = $2.30M
Stage 4 (Proposal): 32 opps × $52K avg = $1.66M
Stage 5 (Negotiation): 18 opps × $55K avg = $0.99M
Total unweighted: $11.72M
Pipeline coverage at quarter start:
Quarterly quota: $4.0M
Unweighted pipeline / quota: 2.93×
Below 3:1 mid-market healthy threshold —
pipeline build needs to accelerate in week 1–4.
For comparison, weighted pipeline using stage probabilities:
Stage 1 (10%): $0.378M
Stage 2 (25%): $0.748M
Stage 3 (40%): $0.920M
Stage 4 (60%): $0.998M
Stage 5 (80%): $0.792M
Total weighted: $3.836M
vs $4.0M quota = $164K projected shortfall absent
stronger close rates or new pipeline build. Unweighted pipeline benchmarks
| Sales motion | Healthy unweighted coverage at quarter start | Top-quartile coverage | Coverage below this is crisis | When weighted view diverges most |
|---|---|---|---|---|
| SMB / inside sales | 3.0–4.0× | 5.0×+ | <2.5× | Late-stage concentration |
| Mid-market | 3.0–4.5× | 5.5×+ | <2.5× | Stage 1–2 over-counting |
| Enterprise | 3.5–5.0× | 6.0×+ | <3.0× | Long-tail Stage 1 deals |
| PLG sales-assist | 2.5–3.5× | 4.5×+ | <2.0× | Activation conversion noise |
| Channel-led | 3.0–4.0× | 5.0×+ | <2.5× | Partner deal-reg without commitment |
Sources: Pavilion 2024 Sales Operations Survey; Bridge Group SaaS AE Benchmarks 2024; OpenView SaaS Benchmarks 2025; Fairview customer data.
Common mistakes when reading unweighted pipeline
1. Forecasting against unweighted pipeline. Unweighted pipeline assumes 100% conversion across all stages. Forecasting from it produces structural over-forecasting equal to (1 − historical win rate) × pipeline value — typically a 70–85% forecast inflation. Use weighted pipeline or cohort conversion for forecasting; reserve unweighted for coverage and capacity views.
2. Including stale or expired pipeline in the unweighted total. Stale deals (no activity in 30+ days, or sitting past 1.5x typical stage duration) inflate unweighted pipeline without adding real opportunity. Apply hygiene scrubbing before reporting unweighted pipeline; otherwise the headline number misleads coverage decisions.
3. Comparing unweighted coverage across companies with different sales-cycle lengths. A team with a 90-day cycle needs 3:1 coverage to plausibly hit the next quarter; a team with 180-day cycle needs 4–5:1 because more pipeline is required to feed the longer funnel. Compare against motion-appropriate benchmarks, not absolute targets.
4. Reporting unweighted pipeline without time-period context. $30M of unweighted pipeline closing over 6 months has different forward-coverage implications than $30M closing over 18 months. Always pair unweighted pipeline with the implied close-date distribution or filter to a specific quarterly window.
5. Confusing unweighted with qualified. Some teams report 'unweighted pipeline' that includes Stage-0 leads or unqualified opportunities — inflating the number. The right measure includes only qualified opportunities (deals that have met the team's defined qualification standard).
How Fairview surfaces unweighted vs weighted pipeline together
Fairview's Pipeline Health Monitor shows unweighted pipeline, weighted pipeline (using cohort-derived stage probabilities, not CRM defaults), and hygiene-adjusted pipeline side by side — so coverage decisions use the right view depending on the question being asked.
The Next-Best Action Engine flags coverage divergence: "Unweighted Q3 coverage is 3.4× quota — within healthy range. Hygiene-adjusted coverage drops to 2.2× because 38% of pipeline is stale or has filler close dates. Weighted pipeline against quota shows a $300K shortfall. Coverage looks healthy on the headline but has substantial quality concentration to address."
Unweighted vs weighted vs hygiene-adjusted pipeline
Weighted pipeline is for forecasting; unweighted is for coverage and capacity. Hygiene-adjusted is the truer base on which both views should be calculated. Operators need all three views for different decisions.
| Unweighted | Weighted | Hygiene-adjusted | |
|---|---|---|---|
| Adjustment applied | None — face value | Stage probability × value | Stale and mis-staged removed |
| Best for | Coverage ratio + capacity sizing | Forecasting + plan tracking | True-coverage diagnosis |
| Risk if used wrong | Over-forecasts revenue | Under-counts top-of-funnel volume | Hides partial-quality deals |
| Reporting cadence | Weekly + at quarter start | Weekly + monthly forecast | Monthly + quarterly review |
At a glance
- Category
- Sales Forecasting
- Related
- 5 terms
Frequently asked questions
What is unweighted pipeline in simple terms?
Unweighted pipeline is the total dollar value of all open opportunities at face value — no stage probability or win-rate adjustment applied. A $100K deal at Stage 1 contributes the full $100K, regardless of the typical close rate. It's the gross-pipeline view used for coverage ratio calculations and capacity planning.
How is unweighted pipeline different from weighted pipeline?
Weighted pipeline multiplies each deal's value by its stage probability — a $100K Stage-1 deal at 25% historical close rate contributes $25K to weighted pipeline. Unweighted ignores probability and uses face value. Use weighted for forecasting; use unweighted for coverage and capacity views.
Should you use unweighted pipeline for forecasting?
No. Unweighted pipeline assumes 100% conversion across all stages, producing structural over-forecasting equal to (1 − historical win rate) × pipeline value. Use weighted pipeline (stage-probability adjusted) or cohort-conversion forecasting for revenue prediction; reserve unweighted for coverage ratio tracking.
What's a healthy unweighted pipeline coverage ratio?
Motion-dependent. SMB / inside sales: 3.0–4.0× of next-quarter quota. Mid-market: 3.0–4.5×. Enterprise: 3.5–5.0×. Below the lower bound at quarter start typically predicts a quota miss; above the upper bound indicates healthy build but possibly over-pipelined relative to capacity.
Should you include stale deals in unweighted pipeline?
No — stale deals (no activity in 30+ days or past 1.5x typical stage duration) inflate unweighted pipeline without representing real forward opportunity. Apply hygiene scrubbing before reporting unweighted pipeline. The hygiene-adjusted unweighted pipeline is the truer signal for coverage decisions.
Sources
- Pavilion 2024 Sales Operations Survey
- Bridge Group SaaS AE Benchmarks 2024
- OpenView SaaS Benchmarks 2025
- Gong State of Revenue Operations 2024
- Fairview customer data (B2B SaaS, 2025)
Fairview is an operating intelligence platform that shows unweighted, weighted, and hygiene-adjusted pipeline side by side — so coverage and forecast decisions each use the right view instead of one number doing both jobs poorly. Start your free trial →
Siddharth Gangal is the founder of Fairview. He built the multi-view pipeline layer after watching CROs forecast revenue against unweighted pipeline — and miss quota by exactly the (1 − win rate) × pipeline gap that the unweighted-vs-weighted distinction would have predicted from week 1.
See it in Fairview
Track Unweighted Pipeline automatically.
14-day free trial. No credit card. First data source connected in 5 minutes.